| Literature DB >> 30283331 |
Gonda Konings1,2, Linda Brentjens1,2, Bert Delvoux1,2, Tero Linnanen3, Karlijn Cornel1,2, Pasi Koskimies3, Marlies Bongers1,2, Roy Kruitwagen1,2, Sofia Xanthoulea1,2, Andrea Romano1,2.
Abstract
Our understanding of the intracrine (or local) regulation of estrogen and other steroid synthesis and degradation expanded in the last decades, also thanks to recent technological advances in chromatography mass-spectrometry. Estrogen responsive tissues and organs are not passive receivers of the pool of steroids present in the blood but they can actively modify the intra-tissue steroid concentrations. This allows fine-tuning the exposure of responsive tissues and organs to estrogens and other steroids in order to best respond to the physiological needs of each specific organ. Deviations in such intracrine control can lead to unbalanced steroid hormone exposure and disturbances. Through a systematic bibliographic search on the expression of the intracrine enzymes in various tissues, this review gives an up-to-date view of the intracrine estrogen metabolisms, and to a lesser extent that of progestogens and androgens, in the lower female genital tract, including the physiological control of endometrial functions, receptivity, menopausal status and related pathological conditions. An overview of the intracrine regulation in extra gynecological tissues such as the lungs, gastrointestinal tract, brain, colon and bone is given. Current therapeutic approaches aimed at interfering with these metabolisms and future perspectives are discussed.Entities:
Keywords: bone; central nervous system; endometrium; estrogens; gastrointestinal tract; intracrinology; lungs
Year: 2018 PMID: 30283331 PMCID: PMC6157328 DOI: 10.3389/fphar.2018.00940
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810